Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled study of Danyi Tablet for chronic prostatitis
ChiCTR-TRC-12002957Phase 3Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- May 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Danyi Tablet in chronic prostatitis (CP) (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: NIH Chronic Prostatitis Symptom Index total score, NIH Chronic Prostatitis Symptom Index pain score and 2 more. Started May 2008; status: completed.
02
Drugs
Danyi Tablet
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR-TRC-12002957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002957.